Testing a new approach for modifying the characteristics of the gums

ISRCTN ISRCTN18042063
DOI https://doi.org/10.1186/ISRCTN18042063
Secondary identifying numbers 2495/S.M
Submission date
07/04/2023
Registration date
24/04/2023
Last edited
07/05/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Recently, more studies have addressed the importance of determining the characteristics of the gums (gingival phenotype) before dental procedures, as they significantly impact the outcome of restorative and regenerative therapy. The aim of this study is to evaluate the change in gum thickness and the width of gum tissue that is keratinized after treatment with either a connective tissue graft or an albumin gel-platelet-rich fibrin mixture (Alb-PRF).

Who can participate?
Patients aged 18 years and over with a thin gingival phenotype

What does the study involve?
The position of the graft is selected at random. The connective tissue graft is inserted and sutured in the first test position and an albumin gel-platelet-rich fibrin mixture (Alb-PRF) prepared from the patient's own blood is inserted in the second test area on the opposite side of the mouth.

What are the possible benefits and risks of participating?
Both CTG and Alb-PRF might improve the gingival phenotype by increasing the thickness and keratinized tissue width of the gums. The methods are safe and there are no expected risks.

Where is the study run from?
Damascus University (Syria)

When is the study starting and how long is it expected to run for?
March 2021 to September 2023

Who is funding the study?
Damascus University (Syria)

Who is the main contact?
Dr Sara Abdulhak, dr.sara.abd.alhak@gmail.com

Contact information

Dr Sara Abdulhak
Scientific

Mazzeh
Damascus
-
Syria

ORCiD logoORCID ID 0009-0007-7676-6271
Phone +963 (0)940407821
Email dr.sara.abd.alhak@gmail.com

Study information

Study designSplit-mouth interventional double-blinded randomized clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific titleClinical comparative study of autologous albumin gel mixed with liquid platelet-rich fibrin (Alb-PRF) vs connective tissue graft to modify the gingival phenotype
Study objectivesThere is no difference between albumin gel-platelet-rich fibrin mixture (Alb-PRF) and connective tissue graft for increasing gingival thickness and keratinized tissue width.
Ethics approval(s)Approved 23/08/2021, Scientific Research and Postgraduate Studies Council (Baramkeh, Damascus, Syria; +963 (0)1133923192; ap.srd@damascusuniversity.edu.sy), ref: 2495/S.M
Health condition(s) or problem(s) studiedThin gingival phenotype
InterventionIn this split-mouth study, individuals with thin gingival phenotypes were randomly treated with a connective tissue graft and an albumin gel-platelet-rich fibrin mixture (Alb-PRF). Allocation will be at random using a sequentially numbered opaque, sealed envelope method. The connective tissue graft will be applied at the gingiva on one side of the mandibular anterior region, and Alb-PRF will be applied on the other side for the same patient. Clinical measurements will be taken every month during the 3-month follow-up period.
Intervention typeProcedure/Surgery
Primary outcome measure1. Gingival thickness measured using a no.15 endodontic spreader (inserted perpendicularly from the vestibular midpoint 1.5 mm apical of the gingival margin through the soft tissue until a hard surface is reached) and a digital caliper to assess the penetration depth at baseline, 1, and 3 months
2. Keratinized tissue width measured from gingival margin to mucogingival junction with the help of a periodontal probe (UNC 15 probe) at baseline, 1, and 3 months
Secondary outcome measures1. Probing depth index measured using a periodontal probe to measure the periodontal pocket depth at baseline, 1, and 3 months
2. Relative attachment level measured using a UNC-15 probe at baseline, 1 and 3 months
3. Pain measured using a visual analogue scale (VAS) at 1 week after surgery
4. Healing measured using a healing index at 1, 2 weeks and 1 month after surgery
Overall study start date11/03/2021
Completion date01/09/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants20 sites (10 for each group)
Key inclusion criteria1. Systemically healthy patients
2. Gingival thickness of the mandibular anterior teeth >1 mm
3. No pregnancy or lactation
4. Non-smokers
5. Adequate plaque control
6. At least 18 years of age
7. No previous periodontal surgery in the area
Key exclusion criteria1. Active orthodontic treatment
2. Previous periodontal surgery
3. Use of any drug that might affect periodontal health
4. Malocclusion, crowding, missing or supernumerary teeth
5. Tooth mobility, bruxism
6. Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy
Date of first enrolment01/09/2021
Date of final enrolment01/06/2022

Locations

Countries of recruitment

  • Syria

Study participating centre

Damascus University
Department of Periodontology
Faculty of Dentistry
Mezzah
Damascus
-
Syria

Sponsor information

Damascus University
University/education

Albaramkeh
Damascus
-
Syria

Phone +963 (0)1133923192
Email info@damascusuniversity.edu.sy
Website http://damasuniv.edu.sy/
ROR logo "ROR" https://ror.org/03m098d13

Funders

Funder type

University/education

Damascus University
Government organisation / Universities (academic only)
Alternative name(s)
University of Damascus, جَامِعَةُ دِمَشْقَ, DU
Location
Syria

Results and Publications

Intention to publish date30/09/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Prof. Dr Tarik Kasem (prof.tarekkasem@hotmail.com).
All of data of the patients will be available on request.
Consent from participants was obtained.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 08/06/2024 07/05/2025 Yes No

Editorial Notes

07/05/2025: Publication reference added.
24/04/2023: Trial's existence confirmed by Damascus University.